Biblio

[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Croce M, Damonte P, Morini M, Pigozzi S, Chiossone L, Vacca P, Bronte V, Barbieri O, Astigiano S. Increased Arginase1 expression in tumor microenvironment promotes mammary carcinogenesis via multiple mechanisms. Carcinogenesis. 2020.
Crocchiolo R, Giordano L, Rimondo A, Bologna M, Sarina B, Morabito L, Bramanti S, Castagna L, Mineri R. Human Herpesvirus 6 replication predicts Cytomegalovirus reactivation after allogeneic stem cell transplantation from haploidentical donor. J Clin Virol. 2016;84:24-26.
Crittenden MR, Baird J, Friedman D, Savage T, Uhde L, Alice A, Cottam B, Young K, Newell P, Nguyen C, et al. Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy. Oncotarget. 2016.
Crittenden SL, Lee CH, Mohanty I, Battula S, Knobel K, Kimble J. Sexual dimorphism of niche architecture and regulation of the germline stem cell pool. Mol Biol Cell. 2019:mbcE19030164.
Crisinel PAlex, Duval M, Crisinel DThuillard, Mallette B, Bellier N, Vachon M-F, Dedeken L, Rousseau C, Tapiero B, Ovetchkine P. Risk of cytomegalovirus infection and disease after umbilical cord blood transplantation in children. Can J Infect Dis Med Microbiol. 2013;24(1):e11-5.
Criscenti G, Longoni A, Di Luca A, De Maria C, Van Blitterswijk CA, Vozzi G, Moroni L. Triphasic scaffolds for the regeneration of the bone-ligament interface. Biofabrication. 2016;8(1):015009.
Crisan AM, Coriu D, Arion C, Colita A, Jardan C. The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia. J Med Life. 2015;8(4):502-508.
Crippa GVaz, Zanetti TAlves, Biazi BIsabela, Baranoski A, Marques LAreal, Coatti GCastello, Lepri SRegina, Mantovani MSérgio. Up and down-regulation of mRNA in the cytotoxicity and genotoxicity of Plumbagin in HepG2/C3A. Environ Toxicol Pharmacol. 2020;75:103328.
Crighton GL, Estcourt LJ, Wood EM, Trivella M, Doree C, Stanworth S. A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev. 2015;9:CD010981.
Cretton S, Saraux N, Monteillier A, Righi D, Marcourt L, Genta-Jouve G, Wolfender J-L, Cuendet M, Christen P. Anti-inflammatory and antiproliferative diterpenoids from Plectranthus scutellarioides. Phytochemistry. 2018;154:39-46.
Crespo L, Hierro-Oliva M, Barriuso S, Vadillo-Rodríguez V, M Montealegre Á, Saldaña L, Gómez-Barrena E, González-Carrasco JLuis, González-Martín MLuisa, Vilaboa N. On the interactions of human bone cells with Ti6Al4V thermally oxidized by means of laser shock processing. Biomed Mater. 2016;11(1):015009.
Crespi M, Dulbecco P, De Ceglie A, Conio M. Strictures in Crohn's Disease: From Pathophysiology to Treatment. Dig Dis Sci. 2020.
Cremisi F. MicroRNAs and cell fate in cortical and retinal development. Front Cell Neurosci. 2013;7:141.
Cremers NAJ, Lundvig DMS, van Dalen SCM, Schelbergen RF, van Lent PLEM, Szarek WA, Regan RF, Carels CE, Wagener FADTG. Curcumin-Induced Heme Oxygenase-1 Expression Prevents H2O2-Induced Cell Death in Wild Type and Heme Oxygenase-2 Knockout Adipose-Derived Mesenchymal Stem Cells. Int J Mol Sci. 2014;15(10):17974-17999.
Crema A, Ledda M, Fioretti D, Lolli MGrazia, Sanchez M, Carico E, Marchese R, Rinaldi M, Lisi A. Combination of cord blood-derived human hepatic progenitors and hepatogenic factors strongly improves recovery after acute liver injury in mice through modulation of the Wnt/β-catenin signaling. J Tissue Eng Regen Med. 2019.
Creighton CJ, Gibbons DL, Kurie JM. The role of epithelial-mesenchymal transition programming in invasion and metastasis: a clinical perspective. Cancer Manag Res. 2013;5:187-95.
Cree BAC, Mares J, Hartung H-P. Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm. Curr Opin Neurol. 2019.
Crea F. Neuroendocrine prostate cancer: long noncoding RNAs to treat an incurable cancer - an interview with Dr Francesco Crea. Epigenomics. 2019.
Crawford HC, di Magliano MPasca, Banerjee S. Signaling Networks that Control Cellular Plasticity in Pancreatic Tumorigenesis, Progression and Metastasis. Gastroenterology. 2019.
Cravero D, Martignani E, Miretti S, Accornero P, Pauciullo A, Sharma R, Donadeu FXavier, Baratta M. Generation of Induced Pluripotent Stem Cells from Bovine Epithelial Cells and Partial Redirection Toward a Mammary Phenotype In Vitro. Cell Reprogram. 2015;17(3):211-220.
Craven L, Herbert M, Murdoch A, Murphy J, Davies JLawford, Turnbull D. Research Into Policy: A Brief History of Mitochondrial Donation. Stem Cells. 2015.
Crasto S, Di Pasquale E. Induced Pluripotent Stem Cells to Study Mechanisms of Laminopathies: Focus on Epigenetics. Front Cell Dev Biol. 2018;6:172.
Crane JL, Xian L, Cao X. Role of TGF-β Signaling in Coupling Bone Remodeling. Methods Mol Biol. 2016;1344:287-300.
Crane AT, Voth JP, Shen FX, Low WC. Human-Animal Neurological Chimeras: Humanized Animals or Human Cells in an Animal?. Stem Cells. 2019.
Crampe M, Garry J, Langabeer SE, Murphy PT. Sustained molecular response with nilotinib in imatinib-intolerant chronic myeloid leukaemia with an e19a2 BCR-ABL1 fusion. Hematol Oncol Stem Cell Ther. 2016.

Pages